Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
Academic Article
Publication Date:
2016
Short description:
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer / Chiorean, ., E., G., Von, H., D., D., Tabernero, ., El-Maraghi, ., Ma, ., W., W., Reni, M., Harris, ., Whorf, ., Liu, ., Li, ., J., S., Manax, ., Romano, ., Lu, ., Goldstein,. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - (2016).
Iris type:
1.1 Articolo in rivista
List of contributors:
Chiorean, ; E., G.; Von, Hoff; D., D.; Tabernero, ; El-Maraghi, ; Ma, ; W., W.; Reni, M; Harris, ; Whorf, ; Liu, ; Li, ; J., S.; Manax, ; Romano, ; Lu, ; Goldstein,
Published in: